MedPath

LANTUS

LANTUS

Discontinued
DIN Number

02280418

Drug Class

Human

Market Date

N/A

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02280418
AIG Number0147062001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
A10AE04 INSULIN GLARGINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

INSULIN GLARGINEActive
Strength: 100 UNIT / ML
Monograph: INSULIN GLARGINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.